Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603579'
s PB Ratio Range Over the Past 10 Years
Min: 1.04 Med: 2.39 Max: 16.81
Current: 1.14
During the past 13 years, Shanghai Rongtai Health Technology's highest PB Ratio was 16.81. The lowest was 1.04. And the median was 2.39.
SHSE:603579's PB Ratio is ranked better than 61.82% of 791
companies
in the Travel & Leisure industry
Industry Median: 1.48
vs SHSE:603579: 1.14
During the past 12 months, Shanghai Rongtai Health Technology's average Book Value Per Share Growth Rate was 21.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 10.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 15.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Rongtai Health Technology was 74.40% per year. The lowest was -11.40% per year. And the median was 6.40% per year.
Back to Basics: PB Ratio
Shanghai Rongtai Health Technology (SHSE:603579) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Shanghai Rongtai Health Technology PB Ratio Related Terms
Shanghai Rongtai Health Technology PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Leisure subindustry, Shanghai Rongtai Health Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Rongtai Health Technology PB Ratio vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's PB Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai Rongtai Health Technology's PB Ratio falls into.
Shanghai Rongtai Health Technology PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Shanghai Rongtai Health Technology (SHSE:603579) has a PB Ratio of 1.14 as of Jul. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Rongtai Health Technology and its competitors. This is 52% below median its historical median of 2.39. Over the past decade, Shanghai Rongtai Health Technology's PB Ratio has ranged from 1.04 to 16.81. According to the industry distribution chart, Shanghai Rongtai Health Technology ranks #302 out of 791 companies in the Travel & Leisure industry, placing it in the top 38.2%.
Is Shanghai Rongtai Health Technology's PB Ratio too high?
Shanghai Rongtai Health Technology's current PB Ratio of 1.14 is 52% below median its 10-year median of 2.39. Over the past 10 years, this metric has ranged from a low of 1.04 to a high of 16.81. The Travel & Leisure industry median PB Ratio is 1.48. Shanghai Rongtai Health Technology's value of 1.14 is 23% below this industry median. Based on the distribution chart, Shanghai Rongtai Health Technology ranks #302 out of 791 companies in the Travel & Leisure industry, which is above the industry midpoint. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's PB Ratio compare to AS and HAS?
According to the Travel & Leisure industry distribution chart, Shanghai Rongtai Health Technology ranks #302 out of 791 companies for PB Ratio. This puts Shanghai Rongtai Health Technology in the upper half of its industry. The industry median PB Ratio is 1.48. Shanghai Rongtai Health Technology's value of 1.14 is 23% below this benchmark. Historically, Shanghai Rongtai Health Technology's own PB Ratio has ranged from 1.04 to 16.81 over the past decade. While the company's 10-year median is 2.39 vs. the industry median of 1.48, Shanghai Rongtai Health Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Travel & Leisure company?
The median PB Ratio among Travel & Leisure companies is 1.48, based on 791 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Rongtai Health Technology's current PB Ratio of 1.14 is 23% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Shanghai Rongtai Health Technology and its competitors. For the Travel & Leisure industry, the median PB Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Rongtai Health Technology's current PB Ratio is 1.14, which is 52% below median its own 10-year median of 2.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.92, compared to a current price of ¥16.30 — trading 2.4% above its estimated fair value. The current PB Ratio is 1.14, which is 52% below median its 10-year median of 2.39 and 23% below the Travel & Leisure industry median of 1.48. Shanghai Rongtai Health Technology's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current PB Ratio is 1.14 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued.
The current stock price of ¥16.30 is trading 2.4% above its estimated GF Value™ of ¥15.92.
GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.
Key valuation signals for SHSE:603579:
PB Ratio: 1.14 (52% below median its 10-year median of 2.39)
GF Value™: ¥15.92 vs. price of ¥16.30 (2.4% above fair value)
Industry Position: 23% below the Travel & Leisure median (#302 of 791)
No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Rongtai Health Technology Business Description
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
68GF Score
Get the complete analysis for SHSE:603579
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603579 has been successfully added to your 
